Fund Holdings — Eagle Health Investments LP

Total Portfolio Value
$380.92M
Total Bought
$40.35M
Total Sold
$68.40M
Net Transaction
-$28.05M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ARGENX SE(ARGX)77,43077,430042,68157,10914.99%+14,428
FORTREA HLDGS INC(FTRE)0988,772+988,77208,3252.19%+8,325
GUARDANT HEALTH INC(GH)212,000284,100+72,10011,03217,7514.66%+6,718
COMPASS PATHWAYS PLC(CMPS)0935,450+935,45005,3601.41%+5,360
SCHOLAR ROCK HLDG CORP(SRRK)269,400363,300+93,9009,54213,5293.55%+3,987
EXACT SCIENCES CORP(EXK)223,750270,950+47,20011,89014,8243.89%+2,934
CENTESSA PHARMACEUTICALS PLC0103,100+103,10002,5000.66%+2,500
ICON PLC(ICLR)202,790182,590-20,20029,49631,9538.39%+2,457
ALKERMES PLC(ALKS)081,800+81,80002,4540.64%+2,454
BRIDGEBIO PHARMA INC(BBIO)259,300259,300011,19713,4683.54%+2,271
IMMUNOCORE HLDGS PLC(IMCR)46,30046,30001,4531,6820.44%+229
VIR BIOTECHNOLOGY INC(VIR)240,500240,50001,2121,3730.36%+161
BIOMARIN PHARMACEUTICAL INC(BMRN)366,812366,812020,16419,8675.22%-297
INTUITIVE SURGICAL INC4,3904,39002,3861,9630.52%-422
AGIOS PHARMACEUTICALS INC(AGIO)330,830246,230-84,60011,0039,8842.59%-1,120
AKERO THERAPEUTICS INC226,400226,400012,08110,7492.82%-1,331
ULTRAGENYX PHARMACEUTICAL IN(RARE)627,600697,000+69,40022,82020,9665.50%-1,854
ILLUMINA INC(ILMN)343,361322,261-21,10032,76030,6058.03%-2,155
INSMED INC(INSM)428,600271,600-157,00043,13439,11310.27%-4,021
ALNYLAM PHARMACEUTICALS INC(ALNY)46,08623,686-22,40015,02810,8012.84%-4,227
NEUROCRINE BIOSCIENCES INC(NBIX)217,200162,800-54,40027,30022,8546.00%-4,446
PROCEPT BIOROBOTICS CORP(PRCT)299,089308,434+9,34517,22811,0082.89%-6,220
NATERA INC(NTRA)235,964203,664-32,30039,86432,7848.61%-7,080
UNITEDHEALTH GROUP INC(UNH)60,8880-60,88818,9950—-18,995
DEXCOM INC(DXCM)273,8210-273,82123,9020—-23,902
Page 1 of 1
Eagle Health Investments LP — 13F Holdings — Q3 2025 | TickerTrail